Clinical Trial Update: Cannabis for Spasticity in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Phase 1/Phase 2 studies evaluating cannabis for spasticity in multiple sclerosis have been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: Center for Medicinal Cannabis Research | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: TERMINATED